JNA 2025 - Actualités bibliographiques : revue de la littérature en recherche clinique - Dr SORIANI

Value of the Information & Strength of the Argument

The presentation provides a valuable synthesis of recent ALS research, offering a balanced view of the current evidence. The speaker critically evaluates each study, noting limitations and conflicting results, which strengthens the argumentation. The selection of studies covers diverse aspects of ALS, from biomarkers to clinical management, providing a comprehensive overview. The speaker also highlights gaps in the literature, such as the lack of studies on assistive technology, and encourages further research. The argumentation is well-structured and supported by the cited studies, though the oral format limits the depth of methodological critique.

The title accurately reflects the content: a review of recent literature in clinical research presented at JNA 2025.

8/10

The presentation is a comprehensive review of recent clinical research in ALS, citing multiple peer-reviewed studies. The speaker demonstrates a critical approach, highlighting limitations and conflicting results. However, the lack of detailed citations and the oral format limit the ability to verify all claims.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and overview of the presentation
• 00:30First study: longitudinal MRI in presymptomatic C9orf72 carriers
• 05:00Discussion of gyrification index as a potential biomarker
• 09:00Study on mechanical insufflation-exsufflation for airway clearance
• 12:00Study on upper airway obstruction during ventilation initiation
• 15:00Validation of the Clinical Saliva Scale
• 17:00Review on assistive technology in ALS
• 18:00Two studies on cognitive and behavioral changes in ALS
• 20:00Sensory involvement in ALS and a review on sensory symptoms
• 21:00Phase 2 clinical trials and concluding remarks

• Longitudinal MRI study in presymptomatic C9orf72 carriers — Discussed at the beginning of the presentation, focusing on atrophy and gyrification as potential biomarkers.
• Study on mechanical insufflation-exsufflation — Multicenter observational study on the use of mechanical insufflation-exsufflation in ALS patients.
• Study on upper airway obstruction during ventilation — Prospective monocentric study using nasofibroscopy to detect upper airway obstruction.
• Validation of the Clinical Saliva Scale — Multicenter study validating a scale for hypersalivation in ALS.
• Review on assistive technology in ALS — Review by Sabrina Paganoni highlighting the lack of research in assistive technology.
• Study on cognitive and behavioral changes in ALS (Italian study) — Longitudinal prospective study on the frequency and progression of cognitive and behavioral changes.
• Study on cognitive and behavioral changes in ALS (Swedish study) — Longitudinal monocentric study by Caroline Ingre's team on cognitive and behavioral changes.
• Case series on sensory neuronopathy in ALS — Report of three patients with ALS and sensory neuronopathy.
• Review on sensory symptoms in ALS — Comprehensive review by Pierre-François and Peter Bidé on sensory symptoms in ALS.
• Phase 2 trial: ROCK ALS — Randomized phase 2 trial of a ROCK inhibitor showing significant results on CV and motor unit number.
• Phase 2 trial: MIROCALS — Randomized phase 2 trial of low-dose interleukin-2, did not meet primary endpoint but showed encouraging subgroup results.
• Phase 2 trial: Trimetazidine — Study on safety and oxidative stress markers.
• Phase 2 trial: TGOPRUBART — Study on neuroinflammation markers.
• Open-label study of Jassifusen — Antisense oligonucleotide therapy showing encouraging results in two patients.

• Longitudinal MRI study in presymptomatic C9orf72 carriers — The findings on atrophy and gyrification are consistent with previous studies on ALS biomarkers.
• Study on cognitive and behavioral changes in ALS (Italian study) — The reported frequency of cognitive impairment aligns with earlier literature.
• Review on sensory symptoms in ALS — The review corroborates the notion of sensory involvement in ALS, supported by neuropathological data.

• Study on cognitive and behavioral changes in ALS (Swedish study) — This study found cognitive and behavioral changes to be stable over time, contradicting the Italian study which reported progression.